Background: In the UK, rates of neonatal postmortem (PM) are low. Consent for PM is required, and all parents should have the opportunity to discuss whether to have a post-mortem examination of their baby. Objectives: We aimed to explore neonatal healthcare professionals’ experiences, knowledge, and views regarding the consent process for post-mortem examination after neonatal death. Method: An online survey of neonatal healthcare providers in the UK was conducted. Responses from 103 healthcare professionals were analysed, 84 of whom were doctors. The response rate of the British Association of Perinatal Medicine (BAPM) members was 11.7%. Results: Perceived barriers to PM included cultural and religious practices of parents as well as a lack of rapport between parents and professionals. Of the respondents, 69.4% had observed a PM; these professionals had improved satisfaction with their training and confidence in counselling (p < 0.001 and p < 0.001) but not knowledge of the procedure (p = 0.77). Healthcare professionals reported conservative estimates of the likelihood that a PM would identify significant information regarding the cause of death. Conclusions: Confidence of neonatal staff in counselling could be improved by observing a PM. Training for staff in developing a rapport with parents and addressing emotional distress may also overcome significant barriers to consent for PM.
Background and aimsNasogastric tube (NGT) feeding is used extensively in neonatal units. Hundreds of feeding tubes are inserted daily without incident. However, there is a risk of the tube being inserted into the respiratory tract or becoming misplaced out of the stomach after the initial insertion.1 A review of cases that were managed for complications of misplaced NGT at a regional tertiary neonatal unit was carried out to understand the clinical presentation, management and outcome.MethodsInfants diagnosed with oesophageal or stomach perforation between 2010 and 2016 were identified on the neonatal unit database. 17 cases of misplaced NGT were identified, 2 cases of suspected right bronchial NGT placement were excluded.Results6 infants were managed for oesophageal perforations and 9 were managed for gastric perforation. All cases of oesophageal perforation occurred in preterm infants weighing less than 1000g and were diagnosed on CXR following intubation or a failed pH indicator test. Oesophageal perforations were managed conservatively with a 7–21 day period of no feeds and antibiotic cover. Video fluoroscopy was used to reinsert a new nasogastric tube as well as excluding leaks or strictures prior to feeding.9 infants who presented with acute abdominal distension and pneumo-peritoneum were found to have stomach perforation at laparotomy. The operating surgeons suspected the gastric perforations to have been caused by an NGT. These cases were initially suspected of perforated necrotising enterocolitis (NEC), but this was excluded at laparotomy. No deaths occurred from complications of misplaced nasogastric tubes in this cohort.Abstract G489(P) Table 1Oesophageal perforation (n=6)Stomach perforation (n=9)Gestational age (mean)25 weeks (23–29)30 weeks 24–37Weight (mean)723g1728gAge at perforation(mean)Day 3 (1–8)Day 4 (3–7)ConclusionLow birth weight infants are at particular risk of perforation from nasogastric tube. It is important to recognise misplaced nasogastric tube before feeding to prevent serious complications. Oesophageal perforations can be managed conservatively without complications. If there is any doubt on the position of and NGT get an X-ray before feeding..ReferencesReducing the harm caused by misplaced naso and orogastric feeding tubes in babies under the care of neonatal units - NPSA
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.